FDA advisers recommend against Delcath's cancer therapy
(Reuters) - A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer therapy for a rare...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/7fkpHSJW10Q/story01.htm
No comments:
Post a Comment